- Home
- INAB vs KNW Comparison
INAB vs KNW Comparison
Compare INAB & KNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- KNW
- Stock Information
- Founded
- INAB 2016
- KNW 1998
- Country
- INAB United States
- KNW United States
- Employees
- INAB N/A
- KNW N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- KNW Industrial Machinery/Components
- Sector
- INAB Health Care
- KNW Industrials
- Exchange
- INAB Nasdaq
- KNW Nasdaq
- Market Cap
- INAB 24.0M
- KNW 23.8M
- IPO Year
- INAB 2021
- KNW N/A
- Fundamental
- Price
- INAB $0.24
- KNW $0.15
- Analyst Decision
- INAB Strong Buy
- KNW Buy
- Analyst Count
- INAB 3
- KNW 1
- Target Price
- INAB $7.75
- KNW $1.00
- AVG Volume (30 Days)
- INAB 750.7K
- KNW 920.7K
- Earning Date
- INAB 11-12-2024
- KNW 02-12-2025
- Dividend Yield
- INAB N/A
- KNW N/A
- EPS Growth
- INAB N/A
- KNW N/A
- EPS
- INAB N/A
- KNW N/A
- Revenue
- INAB N/A
- KNW N/A
- Revenue This Year
- INAB N/A
- KNW N/A
- Revenue Next Year
- INAB N/A
- KNW N/A
- P/E Ratio
- INAB N/A
- KNW N/A
- Revenue Growth
- INAB N/A
- KNW N/A
- 52 Week Low
- INAB $0.22
- KNW $0.13
- 52 Week High
- INAB $1.93
- KNW $0.92
- Technical
- Relative Strength Index (RSI)
- INAB 38.43
- KNW 30.48
- Support Level
- INAB $0.23
- KNW $0.13
- Resistance Level
- INAB $0.32
- KNW $0.37
- Average True Range (ATR)
- INAB 0.03
- KNW 0.04
- MACD
- INAB -0.01
- KNW -0.01
- Stochastic Oscillator
- INAB 10.62
- KNW 7.00
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About KNW Know Labs Inc.
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.